Goldilocks and propofol dosage in older adults: Too much, too little, or just right?
J Am Geriatr Soc
.
2021 Aug;69(8):2106-2109.
doi: 10.1111/jgs.17221.
Epub 2021 May 8.
Authors
Michael J Devinney
1
2
3
4
,
Miles Berger
1
2
3
4
5
6
Affiliations
1
Duke Institute for Brain Sciences, Durham, North Carolina, USA.
2
Department of Anaesthesiology, Duke University Medical Centre, Durham, North Carolina, USA.
3
Duke University School of Medicine, Durham, North Carolina, USA.
4
Centre for the Study of Aging and Human Development, Duke University Medical Centre, Durham, North Carolina, USA.
5
Centre for Cognitive Neuroscience, Duke University, Durham, North Carolina, USA.
6
Duke Brain Imaging and Analysis Centre, Durham, North Carolina, USA.
PMID:
33964173
PMCID:
PMC8373744
DOI:
10.1111/jgs.17221
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Aged
Humans
Propofol* / adverse effects
Substances
Propofol
Grants and funding
K76 AG057022/AG/NIA NIH HHS/United States
P30AG028716/NH/NIH HHS/United States
P30 AG028716/AG/NIA NIH HHS/United States
K76AG057022/NH/NIH HHS/United States